Dr Thomas Duthy

Finance

Brief: Rua faces German supply crunch; Zelira secures equity line; Queensland grower raises $1.4m; Neurotech director exits; CannEpil wins German approval; Cann Group inks Chemist Warehouse deal

April 03, 2025

Finance

Industry Roundup: GrowerIQ, Neurotech International, and Medical Kiwi

February 04, 2025

Premium

Finance

Neurotech Eyes Global Pharma Partnerships for NTI164 While Keeping Australian Rights In-House

August 12, 2024

Premium

Medical

Neurotech Secures A$10m Raise as Autism and Rett Syndrome Drug Trials Show Positive Outcomes

April 17, 2024

Medical

Neurotech Completes Final Patient Visit in ASD Drug Trial, Signs Contract Research Deal with Fenix

April 10, 2024

Medical

Industry Updates: Canntic, Myleaf and Neurotech International

January 31, 2024

Finance

Industry Roundup: Cann Global, Cann Group, InhaleRx, AusCann, Wellnex Life, Neurotech, MGC Pharma, Stenocare

December 04, 2023

Finance

Corporate Updates: Emyria, Wellnex Life, Neurotech International, Melodiol Global Health

November 14, 2023

Medical

Corporate Updates: MGC Pharma, Neurotech International, and Incannex Healthcare

June 01, 2023

Premium

Finance

Industry Roundup: Althea, Cann Group, Emyria, Neurotech, Bod Science, Elixinol, Creso Pharma, MGC Pharma

January 31, 2023

Global

Neurotech Secures FDA Pre-IND Meeting for Autism Cannabis Treatment; Creso Pharma Expands into Manitoba

January 25, 2023

Finance

Industry Updates: Neurotech, Emyria, Cann Group, Incannex, Creso Pharma, Greenfern, Zelira, Organic Genetics

November 24, 2022